These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 19269914)

  • 1. [The factors for progression of the diabetic nephropathy: management and evolution].
    Bouattar T; Ahid S; Benasila S; Mattous M; Rhou H; Ouzeddoun N; Abouqal R; Bayahia R; Benamar L
    Nephrol Ther; 2009 Jun; 5(3):181-7. PubMed ID: 19269914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concomitant macro and microvascular complications in diabetic nephropathy.
    Alwakeel JS; Al-Suwaida A; Isnani AC; Al-Harbi A; Alam A
    Saudi J Kidney Dis Transpl; 2009 May; 20(3):402-9. PubMed ID: 19414942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM; Mauer M;
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microvascular and macrovascular complications in diabetic nephropathy patients referred to nephrology clinic.
    Al-Wakeel JS; Hammad D; Al Suwaida A; Mitwalli AH; Memon NA; Sulimani F
    Saudi J Kidney Dis Transpl; 2009 Jan; 20(1):77-85. PubMed ID: 19112222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Risk factors of diabetic nephropathy progression in patients with a long history of diabetic mellitus as shown by a retrospective analysis].
    Shestakova MV; Koshel' LV; Vagodin VA; Dedov II
    Ter Arkh; 2006; 78(5):60-4. PubMed ID: 16889052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetic retinopathy is a poor predictor of type of nephropathy in proteinuric type 2 diabetic patients.
    Prakash J; Lodha M; Singh SK; Vohra R; Raja R; Usha
    J Assoc Physicians India; 2007 Jun; 55():412-6. PubMed ID: 17879494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silent cerebral infarction in patients with type 2 diabetic nephropathy. Effects of antiplatelet drug dilazep dihydrochloride.
    Nakamura T; Kawagoe Y; Matsuda T; Ueda Y; Ebihara I; Koide H
    Diabetes Metab Res Rev; 2005; 21(1):39-43. PubMed ID: 15386824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The discovery of diabetic nephropathy: from small print to centre stage.
    Cameron JS
    J Nephrol; 2006; 19 Suppl 10():S75-87. PubMed ID: 16874718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered vascular homeostasis in type 2 diabetic nephropathy.
    Futrakul N; Butthep P; Futrakul P
    Ren Fail; 2009; 31(3):207-10. PubMed ID: 19288326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of pregnancy on diabetic nephropathy and retinopathy.
    Irfan S; Arain TM; Shaukat A; Shahid A
    J Coll Physicians Surg Pak; 2004 Feb; 14(2):75-8. PubMed ID: 15228867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetic retinopathy before and after renal transplantation: a longitudinal study.
    Mittal NS; Bajwa GS; Sandhu JS
    Transplant Proc; 2005 Jun; 37(5):2077-9. PubMed ID: 15964343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Examination of the kidneys in a diabetic patient].
    Tesar V
    Vnitr Lek; 2008 May; 54(5):494-8. PubMed ID: 18630635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 'Microalbuminuric anaemia'--the relationship between haemoglobin levels and albuminuria in diabetes.
    Adetunji OR; Mani H; Olujohungbe A; Abraham KA; Gill GV
    Diabetes Res Clin Pract; 2009 Aug; 85(2):179-82. PubMed ID: 19481284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycosaminoglycans urinary excretion as a marker of the early stages of diabetic nephropathy and the disease progression.
    Popławska-Kita A; Mierzejewska-Iwanowska B; Szelachowska M; Siewko K; Nikołajuk A; Kinalska I; Górska M
    Diabetes Metab Res Rev; 2008; 24(4):310-7. PubMed ID: 18273859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Early anemia in diabetic nephropathy].
    Nagy J; Kiss I; Wittmann I
    Orv Hetil; 2005 Feb; 146(9):397-401. PubMed ID: 15830606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recommendations for the management of diabetic patients with nephropathy].
    Rupprecht H; Piehlmeier W
    MMW Fortschr Med; 2005 May; 147(21):43-6. PubMed ID: 15966171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diabetic nephropathy and prevention of diabetic nephropathy caused chronic renal insufficiency].
    Jakić M; Jakić M; Zibar L; Mihaljević D; Stipanić S; Teskera T
    Lijec Vjesn; 2009; 131(7-8):218-25. PubMed ID: 19769285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for development of microalbuminuria in diabetic and nondiabetic normoalbuminuric hypertensives with high or very high cardiovascular risk - a twelve-month follow-up study.
    Cotter J; Oliveira P; Cunha P; Polónia J
    Nephron Clin Pract; 2009; 113(1):c8-15. PubMed ID: 19590230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Frequency of diabetic microangiopathy in newly diagnosed diabetes mellitus in Conakry: late diagnosis and lack of screening].
    Baldé NM; Kaba ML; Baldé MD; Diallo AO; Goépogui A; Diakité M
    Dakar Med; 2007; 52(3):165-70. PubMed ID: 19097396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of microalbuminuria by using losartan in normotensive patients with type 2 diabetes mellitus: A randomized controlled trial.
    Agha A; Amer W; Anwar E; Bashir K
    Saudi J Kidney Dis Transpl; 2009 May; 20(3):429-35. PubMed ID: 19414946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.